Sangam (India) Limited
Sangam (India) Limited (SANGAMIND.NS) Stock Competitors & Peer Comparison
See (SANGAMIND.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SANGAMIND.NS | ₹516.00 | -0.82% | 25.4B | 31.44 | ₹16.41 | +0.39% |
| PAGEIND.NS | ₹37,190.00 | +0.94% | 414.8B | 55.40 | ₹671.34 | +1.61% |
| PAGEIND.BO | ₹36,800.00 | -0.24% | 410.5B | 54.88 | ₹670.59 | +1.61% |
| KPRMILL.NS | ₹936.95 | +1.03% | 320.3B | 37.96 | ₹24.68 | +0.53% |
| KPRMILL.BO | ₹933.15 | +0.55% | 319B | 37.75 | ₹24.72 | +0.53% |
| VTL.NS | ₹612.70 | +0.65% | 177.2B | 21.84 | ₹28.06 | +0.82% |
| VTL.BO | ₹611.35 | +0.36% | 176.9B | 21.82 | ₹28.02 | +0.82% |
| ALOKTEXT.BO | ₹37.04 | +3.81% | 161.2B | -0.72 | -₹51.22 | N/A |
| WELSPUNIND.NS | ₹159.00 | +0.03% | 153B | 29.39 | ₹5.41 | N/A |
| TRIDENT.NS | ₹25.98 | +0.23% | 132.4B | 32.48 | ₹0.80 | +1.92% |
Stock Comparison
SANGAMIND.NS vs PAGEIND.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, PAGEIND.NS has a market cap of 414.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while PAGEIND.NS trades at ₹37,190.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas PAGEIND.NS's P/E ratio is 55.40. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to PAGEIND.NS's ROE of +0.52%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to PAGEIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check PAGEIND.NS's competition here
SANGAMIND.NS vs PAGEIND.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, PAGEIND.BO has a market cap of 410.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while PAGEIND.BO trades at ₹36,800.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas PAGEIND.BO's P/E ratio is 54.88. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to PAGEIND.BO's ROE of +0.52%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to PAGEIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check PAGEIND.BO's competition here
SANGAMIND.NS vs KPRMILL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, KPRMILL.NS has a market cap of 320.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while KPRMILL.NS trades at ₹936.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas KPRMILL.NS's P/E ratio is 37.96. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to KPRMILL.NS's ROE of +0.17%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to KPRMILL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check KPRMILL.NS's competition here
SANGAMIND.NS vs KPRMILL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, KPRMILL.BO has a market cap of 319B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while KPRMILL.BO trades at ₹933.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas KPRMILL.BO's P/E ratio is 37.75. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to KPRMILL.BO's ROE of +0.17%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to KPRMILL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check KPRMILL.BO's competition here
SANGAMIND.NS vs VTL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, VTL.NS has a market cap of 177.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while VTL.NS trades at ₹612.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas VTL.NS's P/E ratio is 21.84. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to VTL.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to VTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check VTL.NS's competition here
SANGAMIND.NS vs VTL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, VTL.BO has a market cap of 176.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while VTL.BO trades at ₹611.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas VTL.BO's P/E ratio is 21.82. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to VTL.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to VTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check VTL.BO's competition here
SANGAMIND.NS vs ALOKTEXT.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ALOKTEXT.BO has a market cap of 161.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ALOKTEXT.BO trades at ₹37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ALOKTEXT.BO's P/E ratio is -0.72. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ALOKTEXT.BO's ROE of +0.03%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ALOKTEXT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ALOKTEXT.BO's competition here
SANGAMIND.NS vs WELSPUNIND.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, WELSPUNIND.NS has a market cap of 153B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while WELSPUNIND.NS trades at ₹159.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas WELSPUNIND.NS's P/E ratio is 29.39. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to WELSPUNIND.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to WELSPUNIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check WELSPUNIND.NS's competition here
SANGAMIND.NS vs TRIDENT.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, TRIDENT.NS has a market cap of 132.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while TRIDENT.NS trades at ₹25.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas TRIDENT.NS's P/E ratio is 32.48. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to TRIDENT.NS's ROE of +0.09%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to TRIDENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check TRIDENT.NS's competition here
SANGAMIND.NS vs TRIDENT.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, TRIDENT.BO has a market cap of 132.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while TRIDENT.BO trades at ₹25.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas TRIDENT.BO's P/E ratio is 32.48. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to TRIDENT.BO's ROE of +0.09%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to TRIDENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check TRIDENT.BO's competition here
SANGAMIND.NS vs WELSPUNLIV.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, WELSPUNLIV.BO has a market cap of 122.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while WELSPUNLIV.BO trades at ₹128.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas WELSPUNLIV.BO's P/E ratio is 52.45. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to WELSPUNLIV.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to WELSPUNLIV.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check WELSPUNLIV.BO's competition here
SANGAMIND.NS vs WELSPUNLIV.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, WELSPUNLIV.NS has a market cap of 122.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while WELSPUNLIV.NS trades at ₹128.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas WELSPUNLIV.NS's P/E ratio is 52.42. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to WELSPUNLIV.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to WELSPUNLIV.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check WELSPUNLIV.NS's competition here
SANGAMIND.NS vs SWANENERGY.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SWANENERGY.BO has a market cap of 104.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SWANENERGY.BO trades at ₹333.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SWANENERGY.BO's P/E ratio is 13.33. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SWANENERGY.BO's ROE of -0.00%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SWANENERGY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SWANENERGY.BO's competition here
SANGAMIND.NS vs ARVIND.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ARVIND.BO has a market cap of 104.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ARVIND.BO trades at ₹398.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ARVIND.BO's P/E ratio is 25.80. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ARVIND.BO's ROE of +0.11%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ARVIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ARVIND.BO's competition here
SANGAMIND.NS vs ARVIND.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ARVIND.NS has a market cap of 104.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ARVIND.NS trades at ₹397.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ARVIND.NS's P/E ratio is 25.72. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ARVIND.NS's ROE of +0.11%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ARVIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ARVIND.NS's competition here
SANGAMIND.NS vs SWANENERGY.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SWANENERGY.NS has a market cap of 103.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SWANENERGY.NS trades at ₹331.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SWANENERGY.NS's P/E ratio is 13.68. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SWANENERGY.NS's ROE of -0.00%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SWANENERGY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SWANENERGY.NS's competition here
SANGAMIND.NS vs MANYAVAR.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, MANYAVAR.BO has a market cap of 103.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while MANYAVAR.BO trades at ₹426.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas MANYAVAR.BO's P/E ratio is 28.64. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to MANYAVAR.BO's ROE of +0.21%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to MANYAVAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check MANYAVAR.BO's competition here
SANGAMIND.NS vs ABFRL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ABFRL.BO has a market cap of 78.1B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ABFRL.BO trades at ₹64.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ABFRL.BO's P/E ratio is -9.19. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ABFRL.BO's ROE of -0.11%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ABFRL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ABFRL.BO's competition here
SANGAMIND.NS vs ABFRL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ABFRL.NS has a market cap of 77.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ABFRL.NS trades at ₹63.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ABFRL.NS's P/E ratio is -9.15. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ABFRL.NS's ROE of -0.11%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ABFRL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ABFRL.NS's competition here
SANGAMIND.NS vs PGIL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, PGIL.BO has a market cap of 71.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while PGIL.BO trades at ₹1,548.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas PGIL.BO's P/E ratio is 27.16. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to PGIL.BO's ROE of +0.23%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to PGIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check PGIL.BO's competition here
SANGAMIND.NS vs PGIL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, PGIL.NS has a market cap of 71.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while PGIL.NS trades at ₹1,542.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas PGIL.NS's P/E ratio is 27.08. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to PGIL.NS's ROE of +0.23%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to PGIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check PGIL.NS's competition here
SANGAMIND.NS vs ALOKINDS.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ALOKINDS.NS has a market cap of 68.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ALOKINDS.NS trades at ₹13.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ALOKINDS.NS's P/E ratio is -9.21. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ALOKINDS.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to ALOKINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ALOKINDS.NS's competition here
SANGAMIND.NS vs GARFIBRES.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GARFIBRES.NS has a market cap of 61B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GARFIBRES.NS trades at ₹615.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GARFIBRES.NS's P/E ratio is 28.75. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GARFIBRES.NS's ROE of +0.17%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to GARFIBRES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GARFIBRES.NS's competition here
SANGAMIND.NS vs GARFIBRES.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GARFIBRES.BO has a market cap of 60.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GARFIBRES.BO trades at ₹610.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GARFIBRES.BO's P/E ratio is 28.57. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GARFIBRES.BO's ROE of +0.17%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to GARFIBRES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GARFIBRES.BO's competition here
SANGAMIND.NS vs ARVINDFASN.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ARVINDFASN.NS has a market cap of 59.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ARVINDFASN.NS trades at ₹446.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ARVINDFASN.NS's P/E ratio is -359.68. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ARVINDFASN.NS's ROE of -0.02%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ARVINDFASN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ARVINDFASN.NS's competition here
SANGAMIND.NS vs ARVINDFASN.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ARVINDFASN.BO has a market cap of 59.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ARVINDFASN.BO trades at ₹444.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ARVINDFASN.BO's P/E ratio is -358.39. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ARVINDFASN.BO's ROE of -0.02%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ARVINDFASN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ARVINDFASN.BO's competition here
SANGAMIND.NS vs ICIL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ICIL.NS has a market cap of 55.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ICIL.NS trades at ₹279.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ICIL.NS's P/E ratio is 46.40. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ICIL.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ICIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ICIL.NS's competition here
SANGAMIND.NS vs ICIL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, ICIL.BO has a market cap of 54.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while ICIL.BO trades at ₹276.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas ICIL.BO's P/E ratio is 33.02. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to ICIL.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to ICIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check ICIL.BO's competition here
SANGAMIND.NS vs GOKEX.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GOKEX.NS has a market cap of 51.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GOKEX.NS trades at ₹707.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GOKEX.NS's P/E ratio is 45.50. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GOKEX.NS's ROE of +0.06%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GOKEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GOKEX.NS's competition here
SANGAMIND.NS vs GOKEX.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GOKEX.BO has a market cap of 51.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GOKEX.BO trades at ₹704.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GOKEX.BO's P/E ratio is 45.11. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GOKEX.BO's ROE of +0.06%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GOKEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GOKEX.BO's competition here
SANGAMIND.NS vs RAYMONDLSL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RAYMONDLSL.NS has a market cap of 48.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RAYMONDLSL.NS trades at ₹797.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RAYMONDLSL.NS's P/E ratio is 90.97. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RAYMONDLSL.NS's ROE of +0.01%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to RAYMONDLSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RAYMONDLSL.NS's competition here
SANGAMIND.NS vs RAYMONDLSL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RAYMONDLSL.BO has a market cap of 48.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RAYMONDLSL.BO trades at ₹796.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RAYMONDLSL.BO's P/E ratio is 91.44. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RAYMONDLSL.BO's ROE of +0.01%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to RAYMONDLSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RAYMONDLSL.BO's competition here
SANGAMIND.NS vs GBGLOBAL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GBGLOBAL.NS has a market cap of 46.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GBGLOBAL.NS trades at ₹930.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GBGLOBAL.NS's P/E ratio is -0.03. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GBGLOBAL.NS's ROE of +0.16%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GBGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GBGLOBAL.NS's competition here
SANGAMIND.NS vs LUXIND.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, LUXIND.NS has a market cap of 42.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while LUXIND.NS trades at ₹1,406.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas LUXIND.NS's P/E ratio is 39.15. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to LUXIND.NS's ROE of +0.06%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to LUXIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check LUXIND.NS's competition here
SANGAMIND.NS vs LUXIND.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, LUXIND.BO has a market cap of 42.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while LUXIND.BO trades at ₹1,401.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas LUXIND.BO's P/E ratio is 39.06. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to LUXIND.BO's ROE of +0.06%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to LUXIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check LUXIND.BO's competition here
SANGAMIND.NS vs TCNSBRANDS.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, TCNSBRANDS.BO has a market cap of 37B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while TCNSBRANDS.BO trades at ₹584.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas TCNSBRANDS.BO's P/E ratio is -11.87. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to TCNSBRANDS.BO's ROE of -0.63%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to TCNSBRANDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check TCNSBRANDS.BO's competition here
SANGAMIND.NS vs TCNSBRANDS.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, TCNSBRANDS.NS has a market cap of 36.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while TCNSBRANDS.NS trades at ₹583.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas TCNSBRANDS.NS's P/E ratio is -11.85. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to TCNSBRANDS.NS's ROE of -0.63%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to TCNSBRANDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check TCNSBRANDS.NS's competition here
SANGAMIND.NS vs KITEX.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, KITEX.BO has a market cap of 32.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while KITEX.BO trades at ₹164.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas KITEX.BO's P/E ratio is -19.45. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to KITEX.BO's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to KITEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check KITEX.BO's competition here
SANGAMIND.NS vs KITEX.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, KITEX.NS has a market cap of 32.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while KITEX.NS trades at ₹164.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas KITEX.NS's P/E ratio is -19.41. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to KITEX.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to KITEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check KITEX.NS's competition here
SANGAMIND.NS vs RAYMOND.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RAYMOND.BO has a market cap of 31.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RAYMOND.BO trades at ₹469.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RAYMOND.BO's P/E ratio is 59.68. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RAYMOND.BO's ROE of +1.44%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RAYMOND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RAYMOND.BO's competition here
SANGAMIND.NS vs RAYMOND.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RAYMOND.NS has a market cap of 31.1B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RAYMOND.NS trades at ₹467.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RAYMOND.NS's P/E ratio is 59.28. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RAYMOND.NS's ROE of +1.44%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RAYMOND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RAYMOND.NS's competition here
SANGAMIND.NS vs KKCL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, KKCL.NS has a market cap of 29.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while KKCL.NS trades at ₹479.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas KKCL.NS's P/E ratio is 21.18. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to KKCL.NS's ROE of +0.16%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to KKCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check KKCL.NS's competition here
SANGAMIND.NS vs KKCL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, KKCL.BO has a market cap of 29.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while KKCL.BO trades at ₹475.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas KKCL.BO's P/E ratio is 21.01. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to KKCL.BO's ROE of +0.16%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to KKCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check KKCL.BO's competition here
SANGAMIND.NS vs GANECOS.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GANECOS.NS has a market cap of 28.1B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GANECOS.NS trades at ₹1,048.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GANECOS.NS's P/E ratio is 70.65. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GANECOS.NS's ROE of +0.03%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GANECOS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GANECOS.NS's competition here
SANGAMIND.NS vs GANECOS.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GANECOS.BO has a market cap of 28B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GANECOS.BO trades at ₹1,047.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GANECOS.BO's P/E ratio is 70.10. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GANECOS.BO's ROE of +0.03%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GANECOS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GANECOS.BO's competition here
SANGAMIND.NS vs JINDWORLD.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, JINDWORLD.NS has a market cap of 26.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while JINDWORLD.NS trades at ₹26.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas JINDWORLD.NS's P/E ratio is 39.53. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to JINDWORLD.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to JINDWORLD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check JINDWORLD.NS's competition here
SANGAMIND.NS vs NITINSPIN.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, NITINSPIN.BO has a market cap of 26B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while NITINSPIN.BO trades at ₹462.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas NITINSPIN.BO's P/E ratio is 15.61. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to NITINSPIN.BO's ROE of +0.13%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to NITINSPIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check NITINSPIN.BO's competition here
SANGAMIND.NS vs SIYSIL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SIYSIL.NS has a market cap of 26B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SIYSIL.NS trades at ₹572.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SIYSIL.NS's P/E ratio is 12.66. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SIYSIL.NS's ROE of +0.16%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to SIYSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SIYSIL.NS's competition here
SANGAMIND.NS vs JINDWORLD.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, JINDWORLD.BO has a market cap of 26B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while JINDWORLD.BO trades at ₹25.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas JINDWORLD.BO's P/E ratio is 39.24. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to JINDWORLD.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to JINDWORLD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check JINDWORLD.BO's competition here
SANGAMIND.NS vs SANGAMIND.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SANGAMIND.BO has a market cap of 25.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SANGAMIND.BO trades at ₹515.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SANGAMIND.BO's P/E ratio is 31.40. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SANGAMIND.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to SANGAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SANGAMIND.BO's competition here
SANGAMIND.NS vs NITINSPIN.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, NITINSPIN.NS has a market cap of 25.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while NITINSPIN.NS trades at ₹461.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas NITINSPIN.NS's P/E ratio is 15.56. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to NITINSPIN.NS's ROE of +0.13%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to NITINSPIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check NITINSPIN.NS's competition here
SANGAMIND.NS vs SIYSIL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SIYSIL.BO has a market cap of 25.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SIYSIL.BO trades at ₹565.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SIYSIL.BO's P/E ratio is 12.69. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SIYSIL.BO's ROE of +0.16%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to SIYSIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SIYSIL.BO's competition here
SANGAMIND.NS vs MAYURUNIQ.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, MAYURUNIQ.BO has a market cap of 24B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while MAYURUNIQ.BO trades at ₹553.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas MAYURUNIQ.BO's P/E ratio is 13.84. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to MAYURUNIQ.BO's ROE of +0.18%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to MAYURUNIQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check MAYURUNIQ.BO's competition here
SANGAMIND.NS vs MAYURUNIQ.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, MAYURUNIQ.NS has a market cap of 23.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while MAYURUNIQ.NS trades at ₹550.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas MAYURUNIQ.NS's P/E ratio is 13.76. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to MAYURUNIQ.NS's ROE of +0.18%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to MAYURUNIQ.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check MAYURUNIQ.NS's competition here
SANGAMIND.NS vs BOMDYEING.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, BOMDYEING.NS has a market cap of 23.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while BOMDYEING.NS trades at ₹113.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas BOMDYEING.NS's P/E ratio is 134.54. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to BOMDYEING.NS's ROE of +0.01%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to BOMDYEING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check BOMDYEING.NS's competition here
SANGAMIND.NS vs BOMDYEING.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, BOMDYEING.BO has a market cap of 23.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while BOMDYEING.BO trades at ₹113.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas BOMDYEING.BO's P/E ratio is 23.99. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to BOMDYEING.BO's ROE of +0.01%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to BOMDYEING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check BOMDYEING.BO's competition here
SANGAMIND.NS vs SPAL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SPAL.NS has a market cap of 20.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SPAL.NS trades at ₹812.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SPAL.NS's P/E ratio is 18.14. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SPAL.NS's ROE of +0.13%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SPAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SPAL.NS's competition here
SANGAMIND.NS vs SPAL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SPAL.BO has a market cap of 20.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SPAL.BO trades at ₹807.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SPAL.BO's P/E ratio is 18.03. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SPAL.BO's ROE of +0.13%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SPAL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SPAL.BO's competition here
SANGAMIND.NS vs FILATEX.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, FILATEX.NS has a market cap of 20.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while FILATEX.NS trades at ₹45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas FILATEX.NS's P/E ratio is 11.01. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to FILATEX.NS's ROE of +0.14%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to FILATEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check FILATEX.NS's competition here
SANGAMIND.NS vs FILATEX.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, FILATEX.BO has a market cap of 20.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while FILATEX.BO trades at ₹45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas FILATEX.BO's P/E ratio is 11.01. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to FILATEX.BO's ROE of +0.14%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to FILATEX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check FILATEX.BO's competition here
SANGAMIND.NS vs CANTABIL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, CANTABIL.NS has a market cap of 20.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while CANTABIL.NS trades at ₹241.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas CANTABIL.NS's P/E ratio is 22.66. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to CANTABIL.NS's ROE of +0.23%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to CANTABIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check CANTABIL.NS's competition here
SANGAMIND.NS vs CANTABIL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, CANTABIL.BO has a market cap of 20.1B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while CANTABIL.BO trades at ₹240.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas CANTABIL.BO's P/E ratio is 22.64. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to CANTABIL.BO's ROE of +0.23%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to CANTABIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check CANTABIL.BO's competition here
SANGAMIND.NS vs SPORTKING.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SPORTKING.NS has a market cap of 18.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SPORTKING.NS trades at ₹148.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SPORTKING.NS's P/E ratio is 15.93. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SPORTKING.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SPORTKING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SPORTKING.NS's competition here
SANGAMIND.NS vs SPORTKING.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SPORTKING.BO has a market cap of 18.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SPORTKING.BO trades at ₹147.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SPORTKING.BO's P/E ratio is 15.86. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SPORTKING.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SPORTKING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SPORTKING.BO's competition here
SANGAMIND.NS vs DOLLAR.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, DOLLAR.NS has a market cap of 17.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while DOLLAR.NS trades at ₹306.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas DOLLAR.NS's P/E ratio is 16.67. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to DOLLAR.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to DOLLAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check DOLLAR.NS's competition here
SANGAMIND.NS vs DOLLAR.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, DOLLAR.BO has a market cap of 17.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while DOLLAR.BO trades at ₹305.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas DOLLAR.BO's P/E ratio is 16.61. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to DOLLAR.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to DOLLAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check DOLLAR.BO's competition here
SANGAMIND.NS vs SUMEETINDS.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SUMEETINDS.NS has a market cap of 15.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SUMEETINDS.NS trades at ₹30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SUMEETINDS.NS's P/E ratio is 0.63. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SUMEETINDS.NS's ROE of +0.90%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SUMEETINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SUMEETINDS.NS's competition here
SANGAMIND.NS vs GOCOLORS.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GOCOLORS.NS has a market cap of 15B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GOCOLORS.NS trades at ₹286.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GOCOLORS.NS's P/E ratio is 23.48. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GOCOLORS.NS's ROE of +0.10%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GOCOLORS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GOCOLORS.NS's competition here
SANGAMIND.NS vs AYMSYNTEX.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, AYMSYNTEX.BO has a market cap of 13.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while AYMSYNTEX.BO trades at ₹236.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas AYMSYNTEX.BO's P/E ratio is -843.04. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to AYMSYNTEX.BO's ROE of -0.00%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to AYMSYNTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check AYMSYNTEX.BO's competition here
SANGAMIND.NS vs AYMSYNTEX.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, AYMSYNTEX.NS has a market cap of 13.4B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while AYMSYNTEX.NS trades at ₹229.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas AYMSYNTEX.NS's P/E ratio is -817.86. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to AYMSYNTEX.NS's ROE of -0.00%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to AYMSYNTEX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check AYMSYNTEX.NS's competition here
SANGAMIND.NS vs RUPA.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RUPA.NS has a market cap of 12.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RUPA.NS trades at ₹152.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RUPA.NS's P/E ratio is 18.20. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RUPA.NS's ROE of +0.07%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RUPA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RUPA.NS's competition here
SANGAMIND.NS vs RUPA.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RUPA.BO has a market cap of 12.1B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RUPA.BO trades at ₹152.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RUPA.BO's P/E ratio is 18.07. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RUPA.BO's ROE of +0.07%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RUPA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RUPA.BO's competition here
SANGAMIND.NS vs RAJRILTD.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RAJRILTD.NS has a market cap of 11.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RAJRILTD.NS trades at ₹21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RAJRILTD.NS's P/E ratio is 50.26. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RAJRILTD.NS's ROE of +0.28%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RAJRILTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RAJRILTD.NS's competition here
SANGAMIND.NS vs MONTECARLO.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, MONTECARLO.NS has a market cap of 11.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while MONTECARLO.NS trades at ₹561.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas MONTECARLO.NS's P/E ratio is 12.05. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to MONTECARLO.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to MONTECARLO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check MONTECARLO.NS's competition here
SANGAMIND.NS vs MONTECARLO.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, MONTECARLO.BO has a market cap of 11.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while MONTECARLO.BO trades at ₹560.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas MONTECARLO.BO's P/E ratio is 12.02. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to MONTECARLO.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to MONTECARLO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check MONTECARLO.BO's competition here
SANGAMIND.NS vs HIMATSEIDE.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, HIMATSEIDE.BO has a market cap of 11.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while HIMATSEIDE.BO trades at ₹88.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas HIMATSEIDE.BO's P/E ratio is 13.11. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to HIMATSEIDE.BO's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to HIMATSEIDE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check HIMATSEIDE.BO's competition here
SANGAMIND.NS vs HIMATSEIDE.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, HIMATSEIDE.NS has a market cap of 11.1B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while HIMATSEIDE.NS trades at ₹88.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas HIMATSEIDE.NS's P/E ratio is 13.46. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to HIMATSEIDE.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to HIMATSEIDE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check HIMATSEIDE.NS's competition here
SANGAMIND.NS vs FAZE3Q.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, FAZE3Q.BO has a market cap of 10.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while FAZE3Q.BO trades at ₹447.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas FAZE3Q.BO's P/E ratio is 34.62. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to FAZE3Q.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to FAZE3Q.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check FAZE3Q.BO's competition here
SANGAMIND.NS vs FAZE3Q.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, FAZE3Q.NS has a market cap of 10.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while FAZE3Q.NS trades at ₹446.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas FAZE3Q.NS's P/E ratio is 34.49. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to FAZE3Q.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to FAZE3Q.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check FAZE3Q.NS's competition here
SANGAMIND.NS vs INDORAMA.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, INDORAMA.BO has a market cap of 10B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while INDORAMA.BO trades at ₹38.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas INDORAMA.BO's P/E ratio is 7.32. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to INDORAMA.BO's ROE of +0.37%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to INDORAMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check INDORAMA.BO's competition here
SANGAMIND.NS vs INDORAMA.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, INDORAMA.NS has a market cap of 9.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while INDORAMA.NS trades at ₹38.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas INDORAMA.NS's P/E ratio is 7.25. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to INDORAMA.NS's ROE of +0.37%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to INDORAMA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check INDORAMA.NS's competition here
SANGAMIND.NS vs CENTENKA.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, CENTENKA.BO has a market cap of 9.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while CENTENKA.BO trades at ₹425.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas CENTENKA.BO's P/E ratio is 15.92. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to CENTENKA.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to CENTENKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check CENTENKA.BO's competition here
SANGAMIND.NS vs CENTENKA.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, CENTENKA.NS has a market cap of 9.2B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while CENTENKA.NS trades at ₹420.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas CENTENKA.NS's P/E ratio is 13.46. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to CENTENKA.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to CENTENKA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check CENTENKA.NS's competition here
SANGAMIND.NS vs NAHARSPING.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, NAHARSPING.BO has a market cap of 8.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while NAHARSPING.BO trades at ₹245.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas NAHARSPING.BO's P/E ratio is 26.58. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to NAHARSPING.BO's ROE of +0.01%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to NAHARSPING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check NAHARSPING.BO's competition here
SANGAMIND.NS vs NAHARSPING.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, NAHARSPING.NS has a market cap of 8.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while NAHARSPING.NS trades at ₹241.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas NAHARSPING.NS's P/E ratio is 44.64. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to NAHARSPING.NS's ROE of +0.01%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to NAHARSPING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check NAHARSPING.NS's competition here
SANGAMIND.NS vs GHCLTEXTIL.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GHCLTEXTIL.NS has a market cap of 8.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GHCLTEXTIL.NS trades at ₹90.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GHCLTEXTIL.NS's P/E ratio is 15.18. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GHCLTEXTIL.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GHCLTEXTIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GHCLTEXTIL.NS's competition here
SANGAMIND.NS vs AMBIKCO.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, AMBIKCO.NS has a market cap of 8.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while AMBIKCO.NS trades at ₹1,493.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas AMBIKCO.NS's P/E ratio is 13.59. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to AMBIKCO.NS's ROE of +0.07%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to AMBIKCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check AMBIKCO.NS's competition here
SANGAMIND.NS vs AMBIKCO.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, AMBIKCO.BO has a market cap of 8.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while AMBIKCO.BO trades at ₹1,488.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas AMBIKCO.BO's P/E ratio is 13.56. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to AMBIKCO.BO's ROE of +0.07%. Regarding short-term risk, SANGAMIND.NS is more volatile compared to AMBIKCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.NS.Check AMBIKCO.BO's competition here
SANGAMIND.NS vs GHCLTEXTIL.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, GHCLTEXTIL.BO has a market cap of 8.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while GHCLTEXTIL.BO trades at ₹89.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas GHCLTEXTIL.BO's P/E ratio is 14.93. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to GHCLTEXTIL.BO's ROE of +0.04%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to GHCLTEXTIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check GHCLTEXTIL.BO's competition here
SANGAMIND.NS vs RUBYMILLS.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RUBYMILLS.BO has a market cap of 7.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RUBYMILLS.BO trades at ₹236.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RUBYMILLS.BO's P/E ratio is 14.74. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RUBYMILLS.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RUBYMILLS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RUBYMILLS.BO's competition here
SANGAMIND.NS vs RUBYMILLS.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RUBYMILLS.NS has a market cap of 7.9B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RUBYMILLS.NS trades at ₹235.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RUBYMILLS.NS's P/E ratio is 16.25. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RUBYMILLS.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RUBYMILLS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RUBYMILLS.NS's competition here
SANGAMIND.NS vs RSWM.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RSWM.BO has a market cap of 7.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RSWM.BO trades at ₹164.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RSWM.BO's P/E ratio is 96.94. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RSWM.BO's ROE of +0.02%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RSWM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RSWM.BO's competition here
SANGAMIND.NS vs RSWM.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, RSWM.NS has a market cap of 7.7B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while RSWM.NS trades at ₹164.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas RSWM.NS's P/E ratio is 39.36. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to RSWM.NS's ROE of +0.02%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to RSWM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check RSWM.NS's competition here
SANGAMIND.NS vs SARLAPOLY.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SARLAPOLY.NS has a market cap of 7.6B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SARLAPOLY.NS trades at ₹90.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SARLAPOLY.NS's P/E ratio is -57.64. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SARLAPOLY.NS's ROE of -0.03%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SARLAPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SARLAPOLY.NS's competition here
SANGAMIND.NS vs SARLAPOLY.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, SARLAPOLY.BO has a market cap of 7.5B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while SARLAPOLY.BO trades at ₹90.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas SARLAPOLY.BO's P/E ratio is 11.10. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to SARLAPOLY.BO's ROE of -0.03%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to SARLAPOLY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check SARLAPOLY.BO's competition here
SANGAMIND.NS vs DIGJAMLTD.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, DIGJAMLTD.NS has a market cap of 7.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while DIGJAMLTD.NS trades at ₹82.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas DIGJAMLTD.NS's P/E ratio is 7.77. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to DIGJAMLTD.NS's ROE of +1.12%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to DIGJAMLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check DIGJAMLTD.NS's competition here
SANGAMIND.NS vs UNITEDPOLY.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, UNITEDPOLY.NS has a market cap of 7.3B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while UNITEDPOLY.NS trades at ₹31.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas UNITEDPOLY.NS's P/E ratio is -7.11. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to UNITEDPOLY.NS's ROE of +0.22%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to UNITEDPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check UNITEDPOLY.NS's competition here
SANGAMIND.NS vs CHEVIOT.BO Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, CHEVIOT.BO has a market cap of 6.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while CHEVIOT.BO trades at ₹1,169.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas CHEVIOT.BO's P/E ratio is 9.76. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to CHEVIOT.BO's ROE of +0.11%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to CHEVIOT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check CHEVIOT.BO's competition here
SANGAMIND.NS vs CHEVIOT.NS Comparison May 2026
SANGAMIND.NS plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANGAMIND.NS stands at 25.4B. In comparison, CHEVIOT.NS has a market cap of 6.8B. Regarding current trading prices, SANGAMIND.NS is priced at ₹516.00, while CHEVIOT.NS trades at ₹1,162.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANGAMIND.NS currently has a P/E ratio of 31.44, whereas CHEVIOT.NS's P/E ratio is 9.70. In terms of profitability, SANGAMIND.NS's ROE is +0.08%, compared to CHEVIOT.NS's ROE of +0.11%. Regarding short-term risk, SANGAMIND.NS is less volatile compared to CHEVIOT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.NS.Check CHEVIOT.NS's competition here